Syndecan-4 Is a Major Syndecan in Primary Human Endothelial Cells In Vitro, Modulated by Inflammatory Stimuli and Involved in Wound Healing

Journal of Histochemistry and Cytochemistry

Volumn 63, Issue 4, 2015, Pages 280-292

  Vuong, Tram Thu ^a   Reine, Trine M ^a   Sudworth, Amanda ^a   Jenssen, Trond G ^b,c   Kolset, Svein O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

angiogenesis; inflammation; primary human endothelial cells; shedding; syndecan 4; wound healing

Indexed keywords

GELATINASE A; GELATINASE B; ILOMASTAT; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; SMALL INTERFERING RNA; SYNDECAN 1; SYNDECAN 2; SYNDECAN 3; SYNDECAN 4;

ANGIOGENESIS; ARTICLE; CELL SHAPE; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOCAL ADHESION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; DRUG EFFECTS; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY;

GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; RNA, SMALL INTERFERING; SYNDECAN-2; SYNDECAN-3; SYNDECAN-4; WOUND HEALING;

EID: 84925603016     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155415568995     Document Type: Article

References (51)

1. Alexopoulou AN,Multhaupt HA,Couchman JR.Syndecans in wound healing, inflammation and vascular biology.Int J Biochem Cell Biol. 2007;39:505-28
2. Beauvais DM,Ell BJ,Mcwhorter AR,Rapraeger AC.Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.J Cell Biol. 2009;206:691-670
3. Bernfield M,Gotte M,Park PW,Reizes O,Fitzgerald ML,Lincecum J,Zako M.Functions of cell surface heparan sulfate proteoglycans.Annu Rev Biochem. 1999;68:729-77
4. Bernfield M,Kokenyesi R,Kato M,Hinkes MT,Spring J,Gallo RL,Lose EJ.Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol. 1992;8:365-93
5. Chalkiadaki G,Nikitovic D,Berdiaki A,Sifaki M,Krasagakis K,Katonis P,Karamanos NK,Tzanakakis GN.Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.Int J Biochem Cell Biol. 2009;41:1323-1331
6. Chaudhuri P,Colles SM,Fox PL,Graham LM.Protein kinase Cδ–dependent phosphorylation of syndecan-4 regulates cell migration.Circ Res. 2005;97:674-681
7. Couchman JR.Transmembrane signaling proteoglycans.Annu Rev Cell Dev Biol. 2010;26:89-114
8. Couchman JR,Pataki CA.An introduction to proteoglycans and their localization.J Histochem Cytochem. 2012;60:885-897
9. De Rossi G,Whiteford JR.A novel role for syndecan-3 in angiogenesis.F1000Res. 2013;2:270
10. Dovas A,Yoneda A,Couchman JR.PKCα-dependent activation of RhoA by syndecan-4 during focal adhesion formation.J Cell Sci. 2006;119:2837-2846
11. Echtermeyer F,Streit M,Wilcox-Adelman S,Saoncella S,Denhez F,Detmar M,Goetinck PF.Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.J Clin Inv. 2001;107:R9-R14
12. Elfenbein A,Lanahan A,Zhou TX,Yamasaki A,Tkachenko E,Matsuda M,Simons M.Syndecan 4 regulates FGFR1 signaling in endothelial cells by directing macropinocytosis.Sci Signal. 2012;5:ra36
13. Fuster MM,Wang L.Endothelial heparan sulfate in angiogenesis.Prog Mol Biol Transl Sci. 2010;93:179-212
14. Fux L,Ilan N,Sanderson RD,Vlodavsky I.Heparanase: busy at the cell surface.Trends Biochem Sci. 2009;34:511-519
15. Gallo R,Kim C,Kokenyesi R,Adzick NS,Bernfield M.Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin.J Investig Dermatol. 1996;107:676-683
16. Gopal S,Bober A,Whiteford JR,Multhaupt HA,Yoneda A,Couchman JR.Heparan sulfate chain valency controls syndecan-4 function in cell adhesion.J Biol Chem. 2010;285:14247-14258
17. Gotte M.Syndecans in inflammation.FASEB J. 2003;17:575-591
18. Heidemann J,Ogawa H,Dwinell MB,Rafiee P,Maaser C,Gockel HR,Otterson MF,Ota DM,Lugering N,Domschke W,Binion DG.Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.J Biol Chem. 2003;278:8508-8515
19. Iozzo RV.Basement membrane proteoglycans: from cellar to ceiling.Nat Rev Mol Cell Biol. 2005;6:646-656
20. Ishiguro K,Kadomatsu K,Kojima T,Muramatsu H,Iwase M,Yoshikai Y,Yanada M,Yamamoto K,Matsushita T,Nishimura M,Kusugami K,Saito H,Muramatsu T.Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice.J Biol Chem. 2001;276:47483-47488
21. Jaffe EA,Nachman RL,Becker CG,Minick CR.Culture of human endothelial cells from umbilical veins. Identification by morphologic and immunologic criteria.J Clin Invest. 1973;52:2745-2756
22. Jakobsson L,Kreuger J,Holmborn K,Lundin L,Eriksson I,Kjellén L,Claesson-Welsh L.Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis.Dev Cell. 2006;10:625-634
23. Lambaerts K,Wilcox-Adelman SA,Zimmermann P.The signaling mechanisms of syndecan heparan sulfate proteoglycans.Curr Opin Cell Biol. 2009;21:662-669
24. Lim HC,Couchman JR.Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases.Biochim Biophys Acta. 2014;1840:2482-2490
25. Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method.Methods. 2001;25:402-408
26. Ilić D,Furuta Y,Kanazawa S,Takeda N,Sobue K,Nakatsuji N,Nomura S,Fujimoto J,Okada M,Yamamoto T.Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.Nature. 1995;377:539-544
27. Mako V,Czucz J,Weiszhar Z,Herczenik E,Matko J,Prohaszka Z,Cervenak L.Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1beta, TNF-alpha, and LPS.Cytometry A. 2010;77:962-970
28. Manon-Jensen T,Itoh Y,Couchman JR.Proteoglycans in health and disease: the multiple roles of syndecan shedding.FEBS J. 2010;277:3876-3889
29. Manon-Jensen T,Multhaupt HA,Couchman JR.Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.FEBS J. 2013;280:2320-2331
30. Martin D,Galisteo R,Gutkind JS.CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.J Biol Chem. 2009;284:6038-6042
31. Matsuo I,Kimura-Yoshida C.Extracellular modulation of Fibroblast Growth Factor signaling through heparan sulfate proteoglycans in mammalian development.Curr Opin Genet Dev. 2013;23:399-407
32. Meen AJ,Oynebraten I,Reine TM,Duelli A,Svennevig K,Pejler G,Jenssen T,Kolset SO.Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.J Biol Chem. 2011;286:2636-2647
33. Miyake M,Goodison S,Urquidi V,Gomes Giacoia E,Rosser CJ.Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways.Lab Invest. 2013;93:768-778
34. Morgan MR,Humphries MJ,Bass MD.Synergistic control of cell adhesion by integrins and syndecans.Nat Rev Mol Cell Biol. 2007;8:957-969
35. Multhaupt HA,Yoneda A,Whiteford JR,Oh ES,Lee W,Couchman JR.Syndecan signaling: when, where and why?.J Physiol Pharmacol. 2009;60:31-38
36. Okina E,Grossi A,Gopal S,Multhaupt HA,Couchman JR.Alpha-actinin interactions with syndecan-4 are integral to fibroblast–matrix adhesion and regulate cytoskeletal architecture.Int J Biochem Cell Biol. 2012;44:2161-2174
37. Okina E,Manon-Jensen T,Whiteford JR,Couchman JR.Syndecan proteoglycan contributions to cytoskeletal organization and contractility.Scand J Med Sci Sports. 2009;19:479-489
38. Partovian C,Ju R,Zhuang ZW,Martin KA,Simons M.Syndecan-4 regulates subcellular localization of mTOR complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells.Mol Cell. 2008;32:140-149
39. Ramnath R,Foster RR,Qiu Y,Cope G,Butler MJ,Salmon AH,Mathieson PW,Coward RJ,Welsh GI,Satchell SC.Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor alpha: a contributor to endothelial cell glycocalyx dysfunction.FASEB J. 2014;28:4686-4699
40. Rehm M,Bruegger D,Christ F,Conzen P,Thiel M,Jacob M,Chappell D,Stoeckelhuber M,Welsch U,Reichart B,Peter K,Becker BF.Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.Circulation. 2007;116:1896-1906
41. Salmon AHJ,Satchell SC.Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability.J Pathol. 2012;226:562-574
42. Saoncella S,Echtermeyer F,Denhez F,Nowlen JK,Mosher DF,Robinson SD,Hynes RO,Goetinck PF.Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers.Proc Natl Acad Sci U S A. 1999;96:2805-2810
43. Stewart MD,Sanderson RD.Heparan sulfate in the nucleus and its control of cellular functions.Matrix Biol. 2014;35:56-59
44. Sumpio BE,Riley JT,Dardik A.Cells in focus: endothelial cell.Int J Biochem Cell Biol. 2002;34:1508-1512
45. Svennevig K,Hoel TN,Thiara AS,Kolset SO,Castelheim A,Mollnes TE,Brosstad F,Fosse E,Svennevig JL.Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass.Perfusion. 2008;23:165-171
46. Takahashi R,Negishi K,Watanabe A,Arai M,Naganuma F,Ohyama Y,Kurabayashi M.Serum syndecan-4 is a novel biomarker for patients with chronic heart failure.J Cardiol. 2011;57:325-332
47. Tanino Y,Chang MY,Wang X,Gill SE,Skerrett S,Mcguire JK,Sato S,Nikaido T,Kojima T,Munakata M,Mongovin S,Parks WC,Martin TR,Wight TN,Frevert CW.Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide.Am J Respir Cell Mol Biol. 2012;47:196-202
48. Teng YH-F,Aquino RS,Park PW.Molecular functions of syndecan-1 in disease.Matrix Biol. 2012;31:3-16
49. Uchimura K,Morimoto-Tomita M,Bistrup A,Li J,Lyon M,Gallagher J,Werb Z,Rosen S.HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.BMC Biochem. 2006;7:2
50. Wilcox-Adelman SA,Denhez F,Goetinck PF.Syndecan-4 modulates focal adhesion kinase phosphorylation.J Biol Chem. 2002;277:32970-32977
51. Xian X,Gopal S,Couchman J.Syndecans as receptors and organizers of the extracellular matrix.Cell Tissue Res. 2010;339:31-46